FDA Disapproves Spinal Product by Medtronic
Submitted by Neeraj Shahane on Sat, 03/12/2011 - 09:27
The Food and Drug Administration did not approve a product by Medtronic, the medical device giant. This has given them a major setback and there are dialogues going on to try and convince the FDA for the same.
University of Otago Signs Contract for Revolutionary Gel
Submitted by Dinesh Chandra Gaur on Tue, 03/01/2011 - 07:43
The University of Otago and the US based Medtronic have recently signed a deal that will come as a big relief to people planning to undergo sinus surgery. Medical technology Company Medtronic has apparently purchased a patent of a medical gel application that helps in healing wounds after a person has undergone sinus surgery.
Medtronics tones down forecast despite good performance
Submitted by Ketan Mukherjee on Wed, 08/25/2010 - 17:07
Medical equipment maker, Medtronics has shown better than expected profit figures but has on the same hand reduced its forecasts figures for the crest of the year.
The firm earned $830 million during the past quarter which is higher than $445 million that it was able to do during the same quarter last year. This means that against 40 cents per share the earnings have now gone up to 76 cents per share.
Medtronic to buy Osteotech
Submitted by Tangaroa Snell on Wed, 08/18/2010 - 16:30
World's largest medical device maker, Medtronic has agreed to buy out Osteotech Inc for $123 million. This company is into the business of bone grafting.
If the deal goes through then the addition of Osteotech will be done to the biologics business.
As per the news reports, Medtronic has offered to pay $6.50 per share for the company. This is 65 per cent premium on the closing share price of Osteotech of $3.94.
